Status:
COMPLETED
Propolis for Patients With Chronic Kidney Disease.
Lead Sponsor:
Universidade Federal Fluminense
Conditions:
Chronic Kidney Diseases
Inflammation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To evaluate the effects of propolis extract on inflammation in participants with chronic kidney disease. Specific objectives To assess before and after the intervention period: * The expression of ...
Detailed Description
Chronic kidney disease (CKD) has chronic systemic inflammation as an important component of multifactorial origin, a factor related to both the progression and outcomes of CKD, being involved in all c...
Eligibility Criteria
Inclusion
- • Aged 18 years or older
- \- with fistula arteriovenous
Exclusion
- Patients pregnant
- Smokers
- Using antibiotics in the last three months
- Using antioxidant supplements as antioxidant vitamins, probiotic, prebiotic, symbiotic and antibiotics in the last three months
- Clinical diagnosis of infectious diseases
- Clinical diagnosis of Cancer
- Clinical diagnosis of AIDS - for PD patients - no peritonitis
Key Trial Info
Start Date :
January 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04411758
Start Date
January 12 2021
End Date
December 31 2023
Last Update
February 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denise Mafra
Niterói, Rio de Janeiro, Brazil